CSE Bulletin: Consolidation - Prophecy DeFi Inc.

CSE Bulletin: Consolidation - Prophecy DeFi Inc.

Prophecy DeFi Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every fifty (50) pre-consolidated common shares.

As a result, the number of outstanding shares will be reduced to approximately 14,984,964 common shares.

The name and symbol will not change.

Please note that all open orders will be canceled at the close of business on December 19, 2025. Dealers are reminded to re-enter their orders taking into account the share consolidation.

_________________________________

Prophecy DeFi Inc. a annoncé une consolidation de ses actions ordinaires émises et en circulation sur la base d'une (1) action ordinaire post-consolidée pour chaque cinquante (50) actions ordinaires pré-consolidées.

En conséquence, le nombre d'actions en circulation sera réduit à environ 14 984 964 actions ordinaires.

Le nom et le symbole ne changeront pas.

Veuillez noter que toutes les commandes ouvertes seront annulées à la fermeture des bureaux le 19 décembre 2025. Les négociants sont invités à ressaisir leurs commandes en tenant compte de la consolidation des actions.

Trading on a Consolidated Basis/Négociation sur une Base Consolidée : Le 22 DEC 2025
Record Date/Date d'Enregistrement : Le 22 DEC 2025
Anticipated Payment Date/Date de Paiement Prévue : Le 22 DEC 2025
Symbol/Symbole : PDFI
NEW/NOUVEAU CUSIP : 74349R 30 3
NEW/NOUVEAU ISIN : CA 74349R 30 3 6
Old/Vieux CUSIP & ISIN : 74349R105/CA74349R1055

 

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com.

Pour toute question ou information complémentaire, veuillez contacter Listings au 416 367-7340 ou par courriel à: Listings@thecse.com.

News Provided by Newsfile via QuoteMedia

PDFI:CC
The Conversation (0)
Sona Nanotech To Hold Investor Webinar To Discuss Follow-up Data From First-in-human Cancer Therapy Study

Sona Nanotech To Hold Investor Webinar To Discuss Follow-up Data From First-in-human Cancer Therapy Study

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/Sona Nanotech Inc. (CSE: SONA,OTC:SNANF) (OTCQB: SNANF) (the "Company", "Sona"), will host an investor webinar on Wednesday, March 18th at 3:30pm ET to discuss follow-up data from its... Keep Reading...
Half Yearly Report and Accounts

Half Yearly Report and Accounts

RocketBoots (ROC:AU) has announced Half Yearly Report and AccountsDownload the PDF here. Keep Reading...
31 December 2025 Appendix 4D and Interim Financial Report

31 December 2025 Appendix 4D and Interim Financial Report

RemSense Technologies (REM:AU) has announced 31 December 2025 Appendix 4D and Interim Financial ReportDownload the PDF here. Keep Reading...
Mockup of person with brain chip like the one Neuralink is creating.

Can You Invest in Neuralink?

Elon Musk's Neuralink has captured the public’s attention and imagination with its futuristic vision of connecting the human brain to computers.Neuralink has drawn interest to the brain computer interface (BCI) sector with its N1 implant, which is undergoing human trials in patients with spinal... Keep Reading...
Laptop with overlay of fluctuating financial graphs and data points.

Tech Weekly: Mega-cap Earnings Dominate Narrow Trading Week

Welcome to the Investing News Network's weekly brief on tech news and tech stocks driving the market. We also break down next week's catalysts to watch to help you prepare for the week ahead.Don't forget to follow us @INN_Technology for real-time news updates!Securities Disclosure: I, Meagen... Keep Reading...
Quarterly Activities/Appendix 4C Cash Flow Report

Quarterly Activities/Appendix 4C Cash Flow Report

RocketBoots (ROC:AU) has announced Quarterly Activities/Appendix 4C Cash Flow ReportDownload the PDF here. Keep Reading...

Interactive Chart

Latest Press Releases

Related News